Myeloma: three-drug combinations prolong time to progression

    loading  Checking for direct PDF access through Ovid

Abstract

With many novel therapies now being incorporated into myeloma management, it is now possible to keep newly diagnosed patients alive for 10 years or longer. But the optimal combination therapy is still unclear.

Related Topics

    loading  Loading Related Articles